Chemotherapy Induced Peripheral Neuropathy Clinical Trials

38 recruitingLast updated: June 17, 2026

There are 38 actively recruiting chemotherapy induced peripheral neuropathy clinical trials across 26 countries. Studies span Not Applicable, Phase 2, Phase 3, Phase 1. Top locations include Houston, Texas, United States, Ann Arbor, Michigan, United States, Atlanta, Georgia, United States. Updated daily from ClinicalTrials.gov.


Chemotherapy Induced Peripheral Neuropathy Trials at a Glance

38 actively recruiting trials for chemotherapy induced peripheral neuropathy are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 20 trials, with the heaviest enrollment activity in Houston, Ann Arbor, and Atlanta. Lead sponsors running chemotherapy induced peripheral neuropathy studies include M.D. Anderson Cancer Center, City of Hope Medical Center, and Bernardino Clavo, MD, PhD.

Browse chemotherapy induced peripheral neuropathy trials by phase

Treatments under study

About Chemotherapy Induced Peripheral Neuropathy Clinical Trials

Looking for clinical trials for Chemotherapy Induced Peripheral Neuropathy? There are currently 38 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Chemotherapy Induced Peripheral Neuropathy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Chemotherapy Induced Peripheral Neuropathy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 38 trials

Recruiting
Not Applicable

Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors

Chemotherapy Induced Peripheral NeuropathyCancerChildhood Cancer
Yale University20 enrolled2 locationsNCT07019259
Recruiting
Not Applicable

Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy Induced Peripheral NeuropathyCIPN - Chemotherapy-Induced Peripheral Neuropathy
Case Comprehensive Cancer Center90 enrolled1 locationNCT07219472
Recruiting
Not Applicable

Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2

Chemotherapy Induced Peripheral NeuropathyGynecologic Cancer
Duke University190 enrolled4 locationsNCT06139458
Recruiting

Understanding and Preventing Cortical Mechanisms of Chemotherapy-induced Peripheral Neuropathy

Chemotherapy Induced Peripheral Neuropathy
M.D. Anderson Cancer Center45 enrolled1 locationNCT06389721
Recruiting
Phase 1

CBG/CBD Oil for Chemotherapy-Induced Peripheral Neuropathy

Chemotherapy Induced Peripheral Neuropathy
Milton S. Hershey Medical Center12 enrolled1 locationNCT07016971
Recruiting
Not Applicable

Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmChemotherapy Induced Peripheral Neuropathy
Mayo Clinic300 enrolled1 locationNCT06945380
Recruiting
Not Applicable

The Role of TRP Channels in CIPN

Chemotherapy Induced Peripheral Neuropathy
Universitaire Ziekenhuizen KU Leuven240 enrolled1 locationNCT04415892
Recruiting
Not Applicable

Extracellular Vesicles and Chemotherapy-Induced Peripheral Neuropathy

Breast CancerLung CancerHead and Neck Cancer+3 more
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico120 enrolled1 locationNCT07558447
Recruiting
Not Applicable

Cryocompression for CIPN

Chemotherapy Induced Peripheral NeuropathyTaxane-induced Peripheral NeuropathyCIPN - Chemotherapy-Induced Peripheral Neuropathy
Dana-Farber Cancer Institute50 enrolled1 locationNCT07064798
Recruiting

Physiologic Measure of VIPN

Chemotherapy Induced Peripheral Neuropathy
Children's National Research Institute40 enrolled1 locationNCT04786977
Recruiting
Phase 3

Capsaicin 179 mg Patch Versus Oral Duloxetine in Patients With Chemotherapy-induced Peripheral Neuropathy

Chemotherapy Induced Peripheral Neuropathy
Institut Cancerologie de l'Ouest274 enrolled11 locationsNCT05840562
Recruiting
Phase 2

Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)

Chemotherapy Induced Peripheral NeuropathyDrug-Induced Nephropathy
VM Therapeutics LLC16 enrolled1 locationNCT07072468
Recruiting
Not Applicable

Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy

Chemotherapy Induced Peripheral Neuropathy
University of Vermont422 enrolled3 locationsNCT04763356
Recruiting
Not Applicable

A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment

Hematopoietic and Lymphatic System NeoplasmMalignant Solid NeoplasmChemotherapy Induced Peripheral Neuropathy
University of Michigan Rogel Cancer Center50 enrolled1 locationNCT07365007
Recruiting
Not Applicable

The Use of Acupuncture to Reduce Chemotherapy Induced Peripheral Neuropathy in Gynaecological Cancer Patients

Chemotherapy Induced Peripheral NeuropathyGynaecological, Urological or Rectal CancerAcupuncture
Karen Kar Loen CHAN75 enrolled1 locationNCT06769061
Recruiting
Not Applicable

Exploring the Benefit of Peripheral Nerve Stimulation in Treating Pain From Chemo-induced Peripheral Neuropathy: A Longitudinal Single Center Feasibility Study

Chemotherapy Induced Peripheral NeuropathyPeripheral Nerve Stimulation
M.D. Anderson Cancer Center10 enrolled1 locationNCT06162403
Recruiting
Not Applicable

VGAIT for Chemotherapy-induced Peripheral Neuropathy

Chemotherapy Induced Peripheral Neuropathy
Massachusetts General Hospital20 enrolled1 locationNCT07177820
Recruiting

Assessing Effect of Spinal Cord Stimulation on Pain and Quality of Life With Chemotherapy-Induced Peripheral Neuropathy

Malignant Solid NeoplasmChemotherapy Induced Peripheral NeuropathyHematopoietic and Lymphoid System Neoplasm
Mayo Clinic20 enrolled1 locationNCT05411523
Recruiting
Phase 2

Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Malignant Solid NeoplasmChemotherapy Induced Peripheral NeuropathyHematopoietic and Lymphoid Cell Neoplasm
M.D. Anderson Cancer Center380 enrolled2 locationsNCT04560673
Recruiting
Phase 2

Phytocannabinoids for Reducing Chronic Chemotherapy-Induced Peripheral Neuropathy in Breast and Colon Cancer Survivors

Breast CarcinomaChemotherapy Induced Peripheral NeuropathyColon Carcinoma
City of Hope Medical Center120 enrolled2 locationsNCT06731894